Mesoporous 2-chlorobenzoylthiourea-modified MCM-41 (2-Cl-BT-MCM-41) was prepared for the first time and loaded with ibuprofen in a supercritical carbon dioxide (sC-CO2) environment. 2-Cl-BT-MCM-41 was prepared and also characterized via XRD, FT-IR, SEM and BET techniques. The (100) and (110) reflections observed at low angle XRD show the mesoporous SiO2 structure. The particule size of nonuniform spheres were observed at a range of 250-305 nm. BET surface areas were calculated as 1506 m 2 / g for MCM-41 and 306 m 2 /g for 2-Cl-BT-MCM-41, respectively. The absorption and releasing studies of ibuprofen were carried out in simulated body fluid. The result revealed that high adsorption capacity for drug with 2-Cl-BT-MCM-41 and slower drug release rate was achieved.
INTRODUCTION
Controlled drug delivery systems (DDS) are formulations that release a drug in a targeted area in the body. Materials obtained by encapsulation of clinically approved drugs will increase the therapeutic effect of the drug and reduce side effects. Biodegradable polymers, polymeric micelles, liposomes, magnetic nanoparticles, hydroxyapatites, calcium phosphate cement (CPC), xerogels, hydrogels and mesoporous silica are used as drug delivery systems. As a disadvantage, hydrolysis leads to deterioration of the polymer-based carrier structure, resulting in a rapid release of drug molecules and non-homogeneous distribution during the separation process. Research is underway to develop inorganic carriers to overcome these disadvantages of polymer systems. Controlled release of drugs from ordering mesoporous materials is an interesting field of application (1). High-order mesoporous silicates are very promising materials with a wide range of possible applications (2) . The porous web of these biocompatible materials can act as a reservoir for the maintenance of drug molecules by increasing the solubility and relative bioavailability of drug molecules. Among the mesopoous silicates, the MCM-41 has a high specific surface area (~ 1150 m 2 /g), a larger pore volume (~ 1 cm 3 /g), and smaller pore size (2-5 nm), thus being a drug carrier. MCM-41 has attracted more attention as a carrier for drug delivery (2) . MCM has been tested for the transport and controlled release of aspirin (3), atenolol (4), captopril (5), coumarin derivatives (6), diflunisal (7), hydrochlorothazide (8) , ibuprofen (9-12), methotrexate (13), naproxine (9) , sertraline hydrochloride (14) , resveratrol (15) , and others (16) (17) . The presence of high concentrations of silanol group on the silica surface makes it possible to modify the pore walls and surfaces by selecting appropriate organic groups. The surface of MCM-41 can be modified with chloropropyl, phenyl, benzyl, mercaptopropyl, cyanopropyl, and aminopropyl groups (18) .
The objective of this work was to study the ibuprofen adsorption and release behavior of 2-Cl-BT-MCM-41 in simulated body fluid. 2-Cl-BT-MCM-41 was prepared and also characterized via XRD, FT-IR, SEM and BET techniques.
MATERIALS AND METHODS

Synthesis of Compounds Synthesis of MCM-41
Typically, 0.6 g of n-cetyltrimethylammonium bromide (CTAB) was first dissolved in 400 mL of deionized water. Then 3.5 mL of 2 mol/L NaOH was added to the solution, followed by adjusting the solution temperature to 80 o C. Subsequently, 2.5 mL of TEOS was added dropwise to the above solution with vigorous stirring. The mixture was stirred for another 2 h to give rise to white precipitates. The obtained solid product was filtered, washed with deionized water and ethanol, and then dried in air. The dried sample was calcined at 550 o C for 1 h in N2 and followed by another 3 h in air to remove the organic template.
Synthesis of 2-Cl-BT-MCM-41
The MCM-41 was functionalized with 3-aminopropyltriethoxysilane in the toluene solution (refluxing for 24 h) according to the conventional procedure (19) . After cooling, the modified mesoporous material was filtered out and washed several times with small portions of toluene and i-propanol to remove an excess of the modifier and possible products of hydrolysis. Finally, the modified mesoporous material was dried overnight in an oven at 95-100 °C under vacuum. The resulting material was designated as MCM-41-NH2.
2-Cl-BT-MCM-41 was synthesized via a reaction between aminopropyl-functionalized mesoporous silica (MCM-41-NH2) and benzoyl isothiocyanate, which normally proceeds completely. A typical procedure included reaction of 9.04x10 -6 mmol (2 g) of aminopropylsilica with 0.50 mL of 2-chlorobenzoyl isothiocyanate (25% excess) in toluene. The resulting solid was filtered out, washed with 50 mL of toluene and 50 mL of ipropanol, and dried under vacuum for 5 h at 90 °C. The final sample with the attached thiourea functionality had a light yellow color. Schematic illustration of the surface present in the 2-Cl-BT-MCM-41 is given in Figure 1 . Characterization X-ray diffraction pattern was recorded on a Bruker D8 using CuKα radiation, with the diffraction angle (2Θ) at range of o . FT-IR spectrum was recorded on Perkin Elmer FT-IR/FIR/NIR spectrometer Frontier ATR system. SEM measurements were recorded with a Jeol Sem-7100-EDX computer controlled digital model device.
BET analyzes were done with Quantachrome Quadrasorb SI device. Absorbance measurements were performed with Pg Instruments UV-Visible spectrometer. Ibuprofen loading and release studies Drug loading studies were carried out via supercritical carbon dioxide (scCO2) system. 1 g of 2-Cl-BT-MCM-41 and 0.8 g ibuprofen were dissolved in 15 mL of ethanol and they were charged to the scCO2 reaction unit at 40 o C and allowed to stand at 200 bar CO2 for 2 hours. The reaction unit's valve was opened to reduce the CO2 pressure and the drug loaded nanostructures were obtained.
The in vitro drug delivery was performed by soaking the sample powder into a simulated body fluid, SBF, at 37 o C and at pH of 7.4, maintaining the ratio SBF volume (mL) per adsorbed ibuprofen mass (mg) equal to 0.8:1. Continuous magnetic stirring was maintained during the delivery to avoid limitation of the delivery rate by external diffusion constraints. The delivered ibuprofen concentration was monitored by UV spectrophotometry at 273 nm. 
RESULTS AND DISCUSSION
FT-IR studies of MCM-41, MCM-41-NH2 and 2-Cl-BT-MCM-41
XRD studies
The XRD pattern and low angle XRD patterns of 2-Cl-BT-MCM-41 are given in Figure 5a 
SEM studies
Surface investigations of the prepared 2-Cl-BT-MCM-41 were carried out by FE-SEM. SEM micrographs are given in Figure 6 . SEM images showed non-uniform spheres at a range of 250-305 nm. 
In vitro Ibuprofen Releasing Studies
To examine the drug release profiles, the cumulative percentages of drug release were plotted against time. The release behavior of ibuprofen from 2-Cl-BT-MCM-41was investigated in the PBS solution for 66 hours. Release of ibuprofen from 2-Cl-BT-MCM-41 in PBS solution (pH = 7.4; 37 o C) is given in Figure 7 . Wave swing is observed in the drug release profiles. This behavior is due to unbalanced distribution of drug molecules from layered matrices, diffusibility, number of layers and thickness, and fluctuations in drug release are observed (20) . 
BET studies
For the prepared MCM-41, the BET surface area was calculated as 1506 m 2 /g and is compatible with the >1000 m 2 /g value given in the literature. In addition, the pore diameter of MCM-41 was found to be 3.61 nm according to the literature. The surface area of 2-Cl-BT-MCM-41 was found to be 306 m 2 /g. Nitrogen adsorption (black) desorption isotherms of MCM-41 and 2-Cl-BT-MCM-41are given in 8a-b. 
CONCLUSION
In this study, mesoporous 2-Cl-BT-MCM-41was synthesized by precipitation method. 2-Cl-BT-MCM-41 was characterized via XRD, FT-IR, SEM and BET techniques. FT-IR spectrum of the 2-Cl-BT-MCM-41, the aromatic vibrations (C-H) were observed at 3000 cm -1 . The carbon-oxygen vibrations (C=O) were also observed at 1700 cm -1 . The (100) and (110) reflections observed at low angle XRD show the mesoporous SiO2 structure. The characterization results confirm that the proposed structures are formed. The surface morphology of the particles was determined by SEM micrographs. The particule size of nonuniform spheres were observed at a range of 250-305 nm. BET surface areas were calculated as 1506 m 2 / g for MCM-41 and 306 m 2 /g 2-Cl-BT-MCM-41, respectively. BET surface area is given as > 1000 m 2 /g value in the literature. Our BET results are compatible with the literature. Ibuprofen was loaded using supercritical carbon dioxide (sC-CO2) environment. The absorption and releasing studies of ibuprofen were carried out in simulated body fluid. The result revealed that high adsorption capacity for drug with 2-Cl-BT-MCM-41 and slower drug release rate was achieved. MCM 41 and 2-Cl-BT-MCM-41 bind with ibuprofen over weak hydrogen interactions. This causes slow releasing.
